Gamida Cell Ltd. in brief
Gamida Cell Ltd. is an unlisted company in the Biotechnology industry, based in Israel. In the year to Dec 2020 it had sales of $0 M and a net loss of $73 M.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Gamida Cell Ltd. timeline
- 2018
- 🔔· approximateInitial public offering on Nasdaq
Events of Gamida Cell Ltd. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about Gamida Cell Ltd.
- Acquisitions and changes
- No longer listed: ticker GMDA is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in Israel: #175 (Jan 2020) · #113 (Jan 2021) · #265 (Jan 2022) · #255 (Dec 2022) · #215 (Jul 2023) · #330 (Jan 2024)
Annual results
- Revenue
- $0 M
- Operating income
- —
- Net income
- $-73 M
Dec-2020 ending year
How Gamida Cell Ltd. compares in Biotechnology
- Revenue$0 M · higher than 0% of 647
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Gamida Cell Ltd.🇮🇱 | $46 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- Dec-2020 ending year
- Balance sheet:
- Dec-2020 ending year
- Profile updated:
- Nov 14, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Gamida Cell Ltd.? Verify and update this profile — free
Show Gamida Cell Ltd.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.